Personal solar UV-A doses received by patients undergoing oral psoralen photochemotherapy for psoriasis
- 1 November 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 105 (5) , 573-577
- https://doi.org/10.1111/j.1365-2133.1981.tb00802.x
Abstract
Patients undergoing oral psoralen photochemotherapy (PUVA) for psoriasis receive a known amount of UV-A in the treatment cubicle and an unknown amount of UV-A from sunlight. In order to measure the solar UV-A dose, 56 patients received a UV-sensitive film badge to be worn from the time they took their psoralen tablet throughout the course of the day, except during treatment. The UV-A doses measured in this way varied from < 0.2-7 J cm-2, with a median I J cm-2. Solar UV-A received by patients who have been photosensitized by 8-MOP may not be insignificant in relation to the treatment dose.This publication has 13 references indexed in Scilit:
- A comment on the routine testing of sunglasses in photochemotherapyBritish Journal of Dermatology, 1980
- A survey of the ultraviolet radiation emissions of photochemotherapy unitsBritish Journal of Dermatology, 1980
- Risks and Benefits of the Treatment of PsoriasisNew England Journal of Medicine, 1979
- COMPARISON OF PHOTOCHEMOTHERAPY AND DITHRANOL IN THE TREATMENT OF CHRONIC PLAQUE PSORIASISPublished by Elsevier ,1979
- A new dosemeter for the measurement of natural ultraviolet radiation in the study of photodermatoses and drug photosensitivityPhysics in Medicine & Biology, 1978
- Photochemotherapy in the treatment of psoriasisBritish Journal of Dermatology, 1977
- Oral Methoxsalen Photochemotherapy for The Treatment of Psoriasis: a Cooperative Clinical TrialJournal of Investigative Dermatology, 1977
- The calculation of the spectral distribution of natural ultraviolet radiation under clear day conditions (for UV dosimeter correction)Physics in Medicine & Biology, 1977
- Photochemotherapy for psoriasis with orally administered methoxsalenArchives of Dermatology, 1976
- The Wave Length Effect Upon Erythemal and Carcinogenic Response in Psoralen Treated Mice11From the Department of Biochemistry, The University of Texas M.D. Anderson Hospital and Tumor Institute and the Departments of Biochemistry and Dermatology, Baylor University College of Medicine, Houston, Texas. Supported by grants from the Robert A. Welch Foundation, Humble Oil and Refining Company and the National Cancer Institute (NCI 2620), U. S. Department of Health, Education and Welfare.Journal of Investigative Dermatology, 1958